Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Burns Ghoshhajra, M.D.

Co-Author

This page shows the publications co-authored by Brian Ghoshhajra and Mark Lindsay.
Connection Strength

1.111
  1. HDAC9 complex inhibition improves smooth muscle-dependent stenotic vascular disease. JCI Insight. 2019 01 24; 4(2).
    View in: PubMed
    Score: 0.212
  2. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018 03 08; 9(1):1009.
    View in: PubMed
    Score: 0.200
  3. Cervical artery dissection expands the cardiovascular phenotype in FBN1-related Weill-Marchesani syndrome. . 2017 Sep; 173(9):2551-2556.
    View in: PubMed
    Score: 0.191
  4. Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. . 2016 10; 170(10):2617-31.
    View in: PubMed
    Score: 0.177
  5. Characteristics and Outcomes of Ascending Versus Descending Thoracic Aortic Aneurysms. Am J Cardiol. 2016 05 15; 117(10):1683-1690.
    View in: PubMed
    Score: 0.174
  6. Spontaneous coronary artery dissection and its association with takotsubo syndrome: Novel insights from a tertiary center registry. Catheter Cardiovasc Interv. 2020 02 15; 95(3):485-491.
    View in: PubMed
    Score: 0.054
  7. Risk Factors, Imaging Findings, and Sex Differences in Spontaneous Coronary Artery Dissection. Am J Cardiol. 2019 06 01; 123(11):1783-1787.
    View in: PubMed
    Score: 0.054
  8. Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain. N Engl J Med. 2017 12 21; 377(25):2475-2484.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.